Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study
Most Cited Paper
in Retinal Development and Disorders
18 Months Post-Publication
Class of 2026
“Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
voretigene neparvovec · RPE65-mediated inherited retinal dystrophy · gene therapy · PERCEIVE study · registry-based observational study · post-authorization safety study · chorioretinal atrophy · Ocular inflammation · Full-field stimulus testing · Visual acuity · treatment-emergent adverse events · Real-world outcomes · viable retinal cells · ocular TEAEs
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026. Accessed 2026-10-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459